Number of Shares
1,115.00
Current Holdings Value*
â‚©770,250.00
% of Portfolio
0.52%
Total Estimate Gain
â‚©-38.06 Mil
% of Total Estimate Gain
-0.69%

ACTIVE M EMERGING MARKETS EQUITY FUND's Samsung BioLogics Co Ltd Holding Summary

As of 2025-03-31, NORTHERN FUNDS held 1,115.00 shares of Samsung BioLogics Co Ltd(XKRX:207940), totaling â‚©770,250.00. This investment constitutes 0.52% of their stock portfolio, and NORTHERN FUNDS now holds 0% of the outstanding Samsung BioLogics Co Ltd(XKRX:207940) stock.

The initial trade took place in 2021Q4. And since then ACTIVE M EMERGING MARKETS EQUITY FUND has made 5 purchases of XKRX:207940, at an average price of â‚©867,611.47, for a total of 6,363.00 shares. In addition, there have been 8 sales at an average price of â‚©831,382.49 for 5,248.00 shares. Based on historical transaction data and XKRX:207940's current price of â‚©1004000.00, ACTIVE M EMERGING MARKETS EQUITY FUND's estimated gain on his XKRX:207940 holdings is â‚©-38.06 Mil, reflecting a -0.69% gain to date.

ACTIVE M EMERGING MARKETS EQUITY FUND XKRX:207940 (â‚©1004000.00) Holding Chart

ACTIVE M EMERGING MARKETS EQUITY FUND XKRX:207940 (â‚©1004000.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price â‚©-/Share
Shares Sold 0 Average Price â‚©-/Share
Current Price â‚©0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1